EXOXEMIS
Microbiological infection caused by bacteria, viruses, fungi, and prions is an important concern in a range of healthcare sectors affecting human health and well-being. Safe and effective microbicidal products are especially critical today, when antimicrobial resistance and the potential for the rapid spread of pathogens have become public-health issues in countries throughout the world. For 20 years, Exoxemis, Inc. has been the leader in the development of broad-spectrum haloperoxidase-based... products for use in high-value product areas, including a biological entity for use in high morbidity/mortality applications. They are committed to integrating their technology with the intellectual, financial, and commercial strengths of prospective partners to develop innovative products and long-term relationships.
EXOXEMIS
Industry:
Biopharma Biotechnology Medical
Founded:
1985-01-01
Address:
Arkansas City, Arkansas, United States
Country:
United States
Website Url:
http://www.exoxemis.com
Total Employee:
11+
Status:
Active
Contact:
15016032270
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Font Awesome
Similar Organizations
Official Site Inspections
http://www.exoxemis.com Semrush global rank: 5.43 M Semrush visits lastest month: 1.56 K
- Host name: host01.alaskapackers.com
- IP address: 72.52.158.167
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
More informations about "Exoxemis"
Home - Exoxemis - a biomedical research company focused on …
Exoxemis has completed three Phase | and one Phase III human clinical trial with 250 human subjects in each arm, at 25 U.S. and 5 Israeli sites, A primary safety end point of the Phase Ill …See details»
About Us - Exoxemis - a biomedical research company focused on …
Exoxemis will design and test MPO formulations to produce a steady stream of new products and seeks to commercialize products with partners who complement our capabilities. Exoxemis is …See details»
Contact-US - Exoxemis - a biomedical research company focused …
Exoxemis, Inc. P.O. Box 7570 Little Rock AR 72217. We welcome inquiries regarding our company, licensing, alliances and product development. For more information, please contact …See details»
Exoxemis - Crunchbase Company Profile & Funding
Organization. Exoxemis . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... For 20 years, …See details»
EXOXEMIS, INC. Company Profile | Omaha, NE - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for EXOXEMIS, INC. of Omaha, NE. Get the latest business insights from Dun & Bradstreet.See details»
EXOXEMIS, INC. Company Profile | Little Rock, AR | Competitors ...
Exoxemis, inc. d&b business directory home / business directory / wholesale trade / merchant wholesalers, nondurable goods / drugs and druggists' sundries merchant wholesalers / united …See details»
Exoxemis Inc Profile: Summary - OpenSecrets
Exoxemis Inc organization profile. Contributions in the 2018 cycle: $1,060,400. Lobbying in 2018: $0. Lobbying in 2017: $0. Outside Spending in the 2018 cycle: $0.See details»
Exoxemis, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Exoxemis, Inc. with its drug pipeline, therapeutic area, technology platform, 12 literature, Disease Domain:Infectious Diseases, Technology Platform ...See details»
Exoxemis - Crunchbase
A biopharmaceutical research and development company, develops haloperoxidase products for prevention and treatment of serious infections.See details»
Exoxemis, Inc. - CMOCRO
Exoxemis, Inc. is a biopharmaceutical research and development company, develops haloperoxidase products for prevention and treatment of serious infections, to address the …See details»
Exoxemis - Company Profile - Tracxn
Dec 19, 2024 Exoxemis is a developer of enzymatic therapeutics for infections caused by bacteria, viruses, fungi, and prions. The company is using Myeloperoxidase (MPO) and …See details»
exoxemis.org
Exoxemis.orgSee details»
Exoxemis - Products, Competitors, Financials, Employees, …
Exoxemis is a biomedical research company focused on the development and commercialization of a topical biological antiseptic system in the healthcare sector. Use the CB Insights Platform …See details»
Exoxemis Inc Profile: Summary - OpenSecrets
Exoxemis Inc organization profile. Contributions in the 2024 cycle: $3,300. Lobbying in 2024: $0. Outside Spending in the 2024 cycle: $0. ... Our organization profiles compile data on …See details»
Vision - Exoxemis - a biomedical research company focused on …
Exoxemis’ MPO system offers an alternative platform from which to build a new series of effective products based upon natural host defense mechanisms. This novel approach is effective …See details»
Exoxemis - Tech Stack, Apps, Patents & Trademarks - Crunchbase
A biopharmaceutical research and development company, develops haloperoxidase products for prevention and treatment of serious infections.See details»
Technology - Exoxemis - a biomedical research company focused …
Exoxemis has created a broad proprietary base of predictive models, know-how, and intellectual property that form the foundation for commercialization efforts. Extensive in vitro and in vivo …See details»
Groundbreaking Research Points Towards Exoxemis ... - Business …
Oct 2, 2019 “Exoxemis is the only biomedical research company in the world that has been able to make MPO in large, pure quantities at a price that makes it suitable for commercial use …See details»
Indications - Exoxemis - a biomedical research company focused …
The Exoxemis MPO technology platform offers an alternative to traditional methods of preventing nosocomial infection without contributing to antimicrobial resistance. Biodefense. Biodefense. …See details»
Publications - Exoxemis - a biomedical research company focused …
A novel enzyme system utilizing myeloperoxidase (MPO) as a potent antimicrobial agent has been developed (Exoxemis, Inc. Little Rock, AR). The MPO system demonstrated both rapid …See details»